NCT06504719 2025-09-15Safety and Efficacy Real-world Data of Trastuzumab Deruxtecan and Sacituzumab GovitecanHellenic Cooperative Oncology GroupCompleted312 enrolled
NCT03255070 2024-02-01A Dose-escalation, Expansion Study of ARX788, in Advanced Solid Tumors Subjects With HER2 Expression (ACE-Pan Tumor 01)Ambrx, Inc.Phase 1 Completed106 enrolled